Literature DB >> 21412444

Effect of Mass Transport in the Synthesis of Partially Acetylated Dendrimer: Implications for Functional Ligand-Nanoparticle Distributions.

Douglas G Mullen1, Emilee L Borgmeier, Ming Fang, Daniel Q McNerny, Ankur Desai, James R Baker, Bradford G Orr, Mark M Banaszak Holl.   

Abstract

Partial acetylation of the amine-terminated poly(amidoamine) dendrimer has been used in the preparation of dendrimer particles conjugated with a wide variety of functional ligands including targeting moieties, therapeutic agents, and dye molecules. The effectiveness of mass transport during the partial acetylation reaction was found to have a major effect on subsequent distributions of dendrimer-ligand components and to be a major source of inconsistency between batches. This study has broad implications for a wide range of nanoparticle-ligand systems because it demonstrates that conjugates with the same mean ligand-particle ratios can have completely different distribution profiles.

Entities:  

Year:  2010        PMID: 21412444      PMCID: PMC3056448          DOI: 10.1021/ma100663c

Source DB:  PubMed          Journal:  Macromolecules        ISSN: 0024-9297            Impact factor:   5.985


  36 in total

1.  The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.

Authors:  Seungpyo Hong; Pascale R Leroueil; István J Majoros; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Chem Biol       Date:  2007-01

2.  Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature.

Authors:  Marina V Backer; Timur I Gaynutdinov; Vimal Patel; Achintya K Bandyopadhyaya; B T S Thirumamagal; Werner Tjarks; Rolf F Barth; Kevin Claffey; Joseph M Backer
Journal:  Mol Cancer Ther       Date:  2005-09       Impact factor: 6.261

3.  Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

Authors:  Jolanta F Kukowska-Latallo; Kimberly A Candido; Zhengyi Cao; Shraddha S Nigavekar; Istvan J Majoros; Thommey P Thomas; Lajos P Balogh; Mohamed K Khan; James R Baker
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

4.  HPLC separation of different generations of poly(amidoamine) dendrimers modified with various terminal groups.

Authors:  Mohammad T Islam; Xiangyang Shi; Lajos Balogh; James R Baker
Journal:  Anal Chem       Date:  2005-04-01       Impact factor: 6.986

5.  Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability.

Authors:  Seungpyo Hong; Pascale R Leroueil; Elizabeth K Janus; Jennifer L Peters; Mary-Margaret Kober; Mohammad T Islam; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Bioconjug Chem       Date:  2006 May-Jun       Impact factor: 4.774

6.  Targeting and inhibition of cell growth by an engineered dendritic nanodevice.

Authors:  Thommey P Thomas; Istvan J Majoros; Alina Kotlyar; Jolanta F Kukowska-Latallo; Anna Bielinska; Andrzej Myc; James R Baker
Journal:  J Med Chem       Date:  2005-06-02       Impact factor: 7.446

7.  A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates.

Authors:  Douglas G Mullen; Ming Fang; Ankur Desai; James R Baker; Bradford G Orr; Mark M Banaszak Holl
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

8.  Self-assembled nanoscale biosensors based on quantum dot FRET donors.

Authors:  Igor L Medintz; Aaron R Clapp; Hedi Mattoussi; Ellen R Goldman; Brent Fisher; J Matthew Mauro
Journal:  Nat Mater       Date:  2003-08-24       Impact factor: 43.841

9.  PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality.

Authors:  István J Majoros; Andrzej Myc; Thommey Thomas; Chandan B Mehta; James R Baker
Journal:  Biomacromolecules       Date:  2006-02       Impact factor: 6.988

Review 10.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

View more
  6 in total

1.  Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform.

Authors:  Douglas G Mullen; Daniel Q McNerny; Ankur Desai; Xue-Min Cheng; Stassi C Dimaggio; Alina Kotlyar; Yueyang Zhong; Suyang Qin; Christopher V Kelly; Thommey P Thomas; Istvan Majoros; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Bioconjug Chem       Date:  2011-03-22       Impact factor: 4.774

2.  Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation.

Authors:  Douglas G Mullen; Mark M Banaszak Holl
Journal:  Acc Chem Res       Date:  2011-08-03       Impact factor: 22.384

3.  Multifunctional trackable dendritic scaffolds and delivery agents.

Authors:  Roey J Amir; Lorenzo Albertazzi; Jenny Willis; Anzar Khan; Taegon Kang; Craig J Hawker
Journal:  Angew Chem Int Ed Engl       Date:  2011-03-09       Impact factor: 15.336

4.  Isolation and characterization of precise dye/dendrimer ratios.

Authors:  Casey A Dougherty; Joseph C Furgal; Mallory A van Dongen; Theodore Goodson; Mark M Banaszak Holl; Janet Manono; Stassi DiMaggio
Journal:  Chemistry       Date:  2014-03-06       Impact factor: 5.236

Review 5.  Multivalent polymers for drug delivery and imaging: the challenges of conjugation.

Authors:  Mallory A van Dongen; Casey A Dougherty; Mark M Banaszak Holl
Journal:  Biomacromolecules       Date:  2014-08-22       Impact factor: 6.988

6.  A Mixed-Surface Polyamidoamine Dendrimer for In Vitro and In Vivo Delivery of Large Plasmids.

Authors:  Bhairavi Srinageshwar; Maria Florendo; Brittany Clark; Kayla Johnson; Nikolas Munro; Sarah Peruzzaro; Aaron Antcliff; Melissa Andrews; Alexander Figacz; Douglas Swanson; Gary L Dunbar; Ajit Sharma; Julien Rossignol
Journal:  Pharmaceutics       Date:  2020-07-03       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.